Effect of early stage kidney disease on cardiac mass: comparison to post-donation renal function

Caroline Rugale1, Guilhem Du Cailar, Pierre Fesler

  • 1Department of Internal Medicine and Nephrology, Centre Hospitalier Universitaire Montpellier, Montpellier, France. caroline.rugale@inserm.fr

Insights

Kidney disease amplifies left ventricular mass in patients with chronic renal failure, independent of blood pressure. This effect is more pronounced in women and linked to factors like aldosterone.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Chronic renal failure increases cardiovascular risk, partly due to left ventricular hypertrophy.
  • Parenchymal kidney disease (KD+) is common in patients with mild to moderate renal failure (stage 2-3).

Purpose of the Study:

  • To evaluate the influence of parenchymal kidney disease on left ventricular geometry in normotensive patients with mild to moderate renal failure.
  • Compare left ventricular geometry between patients with kidney disease (KD+) and healthy kidney donors (KD-).

Main Methods:

  • Retrospective monocentric study involving 50 patients with kidney disease (KD+) and 63 healthy controls (KD-).
  • Echocardiography used to assess left ventricular geometry.
  • Comparison of left ventricular mass (LVM) indexed to body surface area between groups.

Main Results:

  • Left ventricular mass (LVM) indexed to body surface area was significantly greater in KD+ patients compared to KD- subjects.
  • The increase in LVM was more pronounced in women than in men.
  • Multivariate analysis identified kidney disease as an independent determinant of LVM index, irrespective of age, gender, and blood pressure.

Conclusions:

  • Parenchymal kidney disease has an independent amplifying effect on left ventricular mass.
  • This effect may be related to volume overload and/or prohypertrophic factors, such as aldosterone.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...